Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Plos One|September 1, 2009
The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activationDevorah Gur-Wahnon, Zipora Borovsky, Meir Liebergall, et al.Plos One|September 28, 2013
Novel CD47: SIRPα dependent mechanism for the activation of STAT3 in antigen-presenting cellNatan Toledano, Devorah Gur-Wahnon, Adi Ben-Yehuda, et al.Experimental Hematology|February 21, 2007
Contact-dependent induction of regulatory antigen-presenting cells by human mesenchymal stem cells is mediated via STAT3 signalingDevorah Gur-Wahnon, Zipora Borovsky, Shaul Beyth, et al.Cellular Immunology|January 21, 2020
Role of tissue plasminogen activator in clinical aggravation of experimental autoimmune encephalomyelitis and its therapeutic potentialTehila Mizrachi, Devorah Gur-Wahnon, Abd Al-Roof Higazi, et al.Journal of Autoimmunity|January 16, 2014
Tissue plasminogen activator involvement in experimental autoimmune myasthenia gravis: aggravation and therapeutic potentialDevorah Gur-Wahnon, Tehila Mizrachi, Shane Wald-Altman, et al.The EMBO Journal|October 29, 2004
Capicua integrates input from two maternal systems in Drosophila terminal patterningEinat Cinnamon, Devorah Gur-Wahnon, Aharon Helman, et al.Plos One|November 14, 2017
Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillanceDrirh Khare, Neta Goldschmidt, Aya Bardugo, et al.Experimental Dermatology|August 12, 2020
IL6R is a target of miR-197 in human keratinocytesMoamen Masalha, Devorah Gur-Wahnon, Tal Meningher, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 28, 2018
Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid NodulesHaggi Mazeh, Tova Deutch, Adi Karas, et al.Journal of Neuroinflammation|July 10, 2016
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)Adi Vaknin-Dembinsky, Hanna Charbit, Livnat Brill, et al.Pageof 2